Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

BioNTech on course to produce three billion doses of Pfizer-partnered COVID-19 vaccine in 2021

BioNTech on course to produce three billion doses of Pfizer-partnered COVID-19 vaccine in 2021

BioNTech will have help from other major pharma companies, including Novartis and Sanofi, after signing separate manufacturing agreements to bolster production of BNT162b2. ... Novartis is providing support with a production site in the German city of

Healthware Group appoints Yannick Valenti as digital strategy and customer engagement director

Healthware Group appoints Yannick Valenti as digital strategy and customer engagement director He has worked with a number of high profile pharma clients, including Roche, Pfizer, Bayer and Novartis across a range of therapeutics areas.

Novartis announces delay in UK cholesterol drug study

Novartis announces delay in UK cholesterol drug study Tsai addressed the ORION-4 delays amid a discussion of Novartis’ first quarter results for 2021. ... In its Q1 results, Novartis reported a 5% decline in net income during this period, or 7% at constant exchange rates (CER) from the previous year.

Roche’s Ocrevus shows significant benefit in early-stage MS patients

Roche’s Ocrevus shows significant benefit in early-stage MS patients The early-stage data bolsters Ocrevus’ claim in the crowded MS market, particularly against Novartis’ Kesimpta (ofatumumab).

Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses

Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses The CD20 monoclonal antibody (mAb) was originally developed by Danish biotech company Genmab, and subsequently developed and marketed worldwide by Novartis under a licence agreement. ... According to Genmab, Kesimpta is the first B-cell therapy that can

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...